Research into the causes, diagnosis, treatment, and natural history of autism spectrum disorder (ASD) has made great strides in recent years. Compared to what we knew even 20 years ago, we now have a reasonably good understanding of what causes the disorder, how to diagnose it, what the natural history of the disorder is, and, most importantly, the evidence-based treatments that can make a real difference in the lives of children and families. The lens through which much of the research has been done is a focus on risk factors, predictors of poor outcomes, and interventions directed at core deficits. In addition, the prevailing paradigm has been that ASD is a homogeneous disorder, even if variation and individual differences exist at a quantitative level (i.e. ASD is a 'spectrum' disorder). While this lens has been reasonably successful, with the growing appreciation of the heterogeneity of the disorder, there appear to be some lacunae in this research. One of these lacunae is the idea that individuals with ASD can be 'resilient'.
WHAT IS RESILIENCY?
It is first important to understand the meaning of the word 'resilience' in the context of ASD. The term 'resilience' comes from the positive psychology literature and usually refers to individuals who have a 'better than expected outcome' in the face of some adversity. 1 That adversity is usually conceptualized as an external event such as trauma, some type of catastrophe, physical or sexual abuse, negligence, or mental illness in a parent. Individuals who have a 'good' outcome in the face of such adversity are thought to be 'resilient'. Protective factors that account for resiliency were originally considered traits of the individual (such as high IQ or good social skills) that 'protected' children from these types of stress and adversity. Now, however, protective factors and resiliency are thought to reflect individual (i.e. biological, cognitive, and behavioral variables), relational, as well as contextual variables in the environment such as the availability of supportive adults. 2, 3 This model could be applied to ASD if one were to consider the diagnosis itself (or exposure to the risk factors that cause ASD) as a type of adversity. Resiliency then means 'doing better than expected' given the diagnosis of ASD or having a risk factor for ASD. It is somewhat surprising, given the emerging literature on resiliency in children and young people with disabilities more generally, that PubMed offers no citations on resiliency in ASD (search done 12th September 2016). There are many publications on resiliency in parents who have a child with ASD but there are no papers that focus on resiliency within the child with ASD. For example, there are reports on the processes of resiliency in children with chronic medical conditions and general developmental delay. [4] [5] [6] Each of these publications point out how, in spite of their disability, some children do better than expected and have a general sense of well-being, hopefulness, and a sense of empowerment. Why should this not be possible in ASD as well?
RISK FACTORS IN ASD
Before going on to describe examples of resiliency in ASD, it is important to briefly summarize what we know about risk factors for the disorder. One of the most important risk factors for ASD is sex. 7 We know that males are more frequently diagnosed with ASD than females. The sex ratio is generally considered to be roughly 4:1; but the exact mechanism whereby sex acts as a risk factor is currently unknown. A multifactorial, multiple threshold model composed of genetic, hormonal mediating, and environmental mechanisms has been proposed and is generally accepted. 8 Autism spectrum disorder is also a familial disorder. Well-conducted, population-based studies suggest that about 10 per cent of siblings of a child with ASD are affected with ASD themselves. 9 We know that much of the familiality of ASD is due to genetics factors. There is evidence from twin studies that perhaps more than 90 per cent of the phenotypic variance in ASD can be accounted for by genetic factors. 10 Recent work based on microarrays and whole exome sequencing has reported that many rare de novo and (fewer) inherited genetic variants seem to account for an increasing number of cases of ASD probably on a background of common genetic variants that have yet to be identified. 11 The de novo genetic variants can include single nucleotide variants, insertions or deletions, and copy number variants. Hundreds of rare de novo genetic variants have been reported to be risk factors for ASD, the majority of which are associated with neuronal signaling and development, synaptic function, and chromatin regulation. 12 This number will likely increase as groups are now using whole genome sequencing to implicate non-exonic regions of the genome as well. 13 There is also evidence from twin studies that shared environmental factors may be important although the exact nature of these factors is not well understood.
14 These environmental risk factors are likely prenatal in origin and possibly include maternal diabetes, prematurity, maternal obesity, vitamin D or folic acid deficiency, or air pollution. 15 Further studies will be required to determine which of these is a true risk factor.
EXAMPLES OF RESILIENCY IN ASD
Given this background, there are at least three examples of resiliency in ASD that are worth highlighting. These include the protective effects in females, the variable expression of ASD in younger siblings of children affected with ASD, and better than expected outcomes observed in natural history studies of ASD.
Sex differences
Studies of sex differences report that females with ASD, particularly those without cognitive disability, are less well recognized compared to males. 16 Females with ASD of similar cognitive ability have fewer repetitive behaviors and may have better social communication skills than males with ASD. 17 This variable phenotypic expression might lead to systematic underdiagnosis of females relative to males. There is also emerging work that females with ASD might be able to 'camouflage' their presentation which might add to the risk of misdiagnosis. 18 The most popular way of explaining these sex differences in ASD is to think of a multiple threshold model. In this model, the genetic liability for ASD is normally distributed in the population but there is one threshold for males (above which they are affected) and a higher threshold for females. The implication of this model is that the minimum genetic liability sufficient to cause ASD in females is greater than it is in males. Females need a greater risk factor load to be affected than males.
At least three predictions follow from this multiple threshold model. If it is true that females require a higher load of genetic risk factors to show ASD, then next generation sequencing and microarrays should show sex differences in the mutational load associated with ASD. Second, the male relatives of affected females should be at higher risk for ASD than male relatives of affected males. Third, some females can carry the risk factor that would cause ASD in a male but not be affected. There is now emerging evidence to support these predictions.
Data come from studies of the 'Carter effect', which look at risk and genetic variant burden in males and females separately. There is now some evidence that females with ASD do in fact carry more risk variants than males with ASD. 19 There is also evidence that relatives of females with ASD are at higher risk of being affected with ASD than relatives of males. 20 A good example of how this protective effect might operate comes from pedigree studies of inherited genetic mutations associated with ASD. Sato et al. reported on a family segregating a variant in the SHANK1 gene through four generations. 21 This pedigree illustrates that males who have inherited the deletion have 100 per cent penetrance for ASD whereas the females who have inherited the deletion are unaffected except perhaps for anxiety traits. This is a rare example of an inherited risk variant segregating across several generations where penetrance varies by sex. Although this is a rare example, used more for illustration, perhaps more such examples will be forthcoming as we learn more about inherited variants in ASD from whole genome sequencing on multigenerational families.
Infant siblings
A second illustration of resiliency comes from infant sibling studies in which mothers who already have one child with autism are followed through the birth and early childhood of their new infant. Since these infant siblings are at risk of ASD, investigators can chart and describe the unfolding of ASD from a longitudinal perspective. At roughly 3 years of age, these infants undergo a comprehensive blind assessment to determine whether or not they have ASD or any other phenotype that might be of interest. A pooled sample from the Baby Siblings Research Consortium reported that roughly 20 per cent of the infant siblings developed ASD. 22 But it is the subgroup who do not develop ASD that is of interest to studies of resiliency.
What this paper adds
• Resiliency in autism spectrum disorder is a function of the vast variation seen in etiology and outcome.
• A focus on strengthening protective factors may improve long-term outcome.
Several studies have reported that some of these 'unaffected' siblings also demonstrate difficulties in socialization and communication. For example, Georgiades et al. reported that among the siblings without ASD about 20 per cent experienced these other developmental challenges including high scores on measures of anxiety. 23 Other studies have reported similar estimates. 24 Presumably, these infant siblings have the risk factor for ASD but do not develop the full syndrome. Something protects them from developing ASD in spite of the fact that they probably carry some genetic risk factors for the disorder. Again, it is interesting to note that the sex ratio in these unaffected siblings with developmental challenges is more equal than the ratio seen in affected children, implying that females may carry the risk factor for ASD but be unaffected. What protects these siblings with other developmental challenges from developing ASD is not known, but is an important and fascinating question.
Natural history
Longitudinal studies of ASD provide a third illustration of resiliency. Follow-up studies of ASD children to adulthood suggest that roughly 10 to 15 per cent of adults with ASD have a good adult outcome. 25 There is now also an emerging literature on 'optimal' outcomes in ASD. These are children who no longer meet criteria for ASD and are functioning well (even if they have more subtle difficulties in executive function and communication, see Orinstein et al.) . 26 The existence of such children does illustrate that perhaps the proportion of children with ASD who have a 'better than expected outcome' is greater now that the criteria for ASD has broadened and the proportion of individuals with ASD with typical IQ has increased compared to previous years.
Pathways in ASD is a multisite longitudinal study of children with ASD identified between 2 years and 4 years of age and followed prospectively. 27 Growth mixture models were used to identify distinctive developmental trajectories of symptom severity and adaptive functioning. The majority of children (roughly 90%) had more severe autism symptoms that were stable from the point of diagnosis until 6 years of age. There was a second group (making up about 10% of the sample) that had less severe symptoms at inception and continued to show decreasing symptoms in ASD over time. A slightly different picture emerged looking at trajectories of adaptive functioning. A three-trajectory model provided the best fit to the data. There was one group that was higher functioning at the beginning and showed a rapid increase in skill development (approximately 20% of the group) compared to the rest of the sample. What was surprising, however, was that there was only a moderate degree of overlap between the better outcome group in symptom severity and in adaptive functioning. It was possible for the group with relatively severe and stable autistic symptoms to be in the adaptive functioning group that makes rapid improvement. In other words a child might be resilient on one outcome but not necessarily on another. Similar heterogeneous developmental trajectories have been seen in other studies of ASD and usually identify at least one 'resilient' group who show better than expected improvement (see Gotham et al.) . 28 Other longitudinal studies have looked at protective factors that are associated with a 'better than expected outcome' in ASD. These include the role of supported employment for adults with ASD 29 and other family-related variables. For example, important work by Seltzer et al. 30 highlight the importance of inclusive educational environments and positive parenting in promoting resilient outcomes. In this program of research, roughly 400 adolescents and adults with ASD were followed for an average of 8 years and developmental trajectories of maladaptive behavior, autism symptoms, and daily living skills were estimated. Predictors of trajectory membership included maternal expressed emotion and early inclusion in social and academic activities. Two developmental trajectories were found to best fit the data; one (roughly 43% of the sample) not only had fewer autistic symptoms and better daily living skills at inception but also improved on those dimensions at a faster rate than the other group. What was remarkable was that the number of positive comments (i.e. praise) by the mother when the child was around 10 years of age, and a history of partial or full inclusion at school, were associated with the 'desirable' trajectory, even controlling for initial severity of ASD in childhood. 31, 32 These findings highlight potentially important modifiable protective factors that could support young people with ASD to move from trajectories associated with a poor outcome to a more resilient one.
CONCLUSION
The resilience of each individual in the face of adversity is the result of the interaction between risk and protective factors. This interaction can occur at several levels ranging from the molecular to the individual and from the relational to the contextual. Resilience is a natural consequence of appreciating the heterogeneity seen in the natural history of ASD and can refer to a 'better than expected outcome' in the context of exposure to the risk factors associated with the disorder (as in female sex and infant siblings not receiving a diagnosis of ASD) or in the context of the severity of the clinical presentation itself. Resilience is a complex phenomenon and really depends on the specific developmental phenotype under consideration, whether that includes mental health, socialization, communication, or physical health. Just as the resiliency literature has recognized in general, 2 an individual with ASD may be resilient in one domain but not another and at one developmental stage but not another.
The focus of much of the research in ASD has been on risk factors and on the prediction of a 'poor' outcome. The study of resilience in ASD has been largely ignored. Have we missed important translational opportunities as a result? Many interventions focus primarily on modifying risk factors or core deficits associated with a poor outcome in ASD (poor scores on language, joint attention, or theory of mind).
A focus on strengthening protective factors associated with resiliency may also have a substantial impact on outcome.
Protective factors that account for resiliency are not the opposite or the absence of risk factors. They are effect modifiers, variables that attenuate the impact of a risk factor associated with severity or a poor prognosis. Thus, longitudinal studies on the processes of resiliency are needed that identify protective factors at multiple levels. These might include modifier genes, relative cognitive or behavioral strengths in ASD (such as rote memory or honesty), and family-based (such as positive parenting) and contextual variables (such as an accommodating, inclusive school) that impact outcome to a favorable degree. Once those variables have been identified in prospective studies, they should be the target of controlled trials to see if supporting strengths can function to promote resiliency. Studies of resiliency of this sort in ASD will require a shift away from the simple risk factor and outcome model towards an ecological model that incorporates the dynamic interaction of risk and protective factors nested within individual and environment contexts.
However, much needs to be learned. What is it that really accounts for the female protective effect? What protects some siblings from developing ASD even though they carry the genetic mutational load for ASD? What individual, family, and contextual variables account for the better than expected outcomes in some children with ASD? These are largely unexplored questions, the answers to which may have many important implications for the potential of our field to impact the daily lives of people with ASD and their families.
It is also important to make sure that the voices of parents and individuals with ASD are heard and incorporated into our definition of resiliency. What is an 'optimal' or a 'better than expected' outcome from the perspective of a person with ASD and through the context of neurodiversity? A 'good' outcome is a value-laden concept and one that cannot be defined by scientists or clinicians in isolation. The criteria for identifying resiliency should arise from a consensus of all concerned. Only in this way will real life outcomes be measured in our research and eventually improved.
